US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 3.970
  • +0.380+10.58%
Close Aug 9 16:00 ET
  • 4.000
  • +0.030+0.76%
Post 20:01 ET
248.33MMarket Cap-9232P/E (TTM)

Corvus Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.57%5.94M
-4.88%6.25M
-28.12%23.41M
-0.26%5.65M
-55.42%5.56M
-19.83%5.62M
-11.32%6.57M
-15.70%32.57M
-16.80%5.67M
37.87%12.47M
Selling and administrative expenses
10.10%1.82M
10.00%2.18M
-15.02%6.88M
4.16%1.65M
-24.34%1.6M
-20.86%1.65M
-14.40%1.98M
-14.90%8.1M
-21.56%1.59M
2.53%2.11M
-General and administrative expense
10.10%1.82M
10.00%2.18M
-15.02%6.88M
4.16%1.65M
-24.34%1.6M
-20.86%1.65M
-14.40%1.98M
-14.90%8.1M
-21.56%1.59M
2.53%2.11M
Research and development costs
3.68%4.11M
-11.30%4.08M
-32.46%16.53M
-1.99%4M
-61.75%3.97M
-19.40%3.97M
-9.92%4.59M
-15.96%24.47M
-14.79%4.08M
48.26%10.37M
Operating profit
-5.57%-5.94M
4.88%-6.25M
28.12%-23.41M
0.26%-5.65M
55.42%-5.56M
19.83%-5.62M
11.32%-6.57M
15.70%-32.57M
16.80%-5.67M
-37.87%-12.47M
Net non-operating interest income expense
7.69%434K
-15.96%316K
142.20%1.58M
19.50%380K
88.89%425K
303.00%403K
3,318.18%376K
4,460.00%654K
4,075.00%318K
2,145.45%225K
Non-operating interest income
7.69%434K
-15.96%316K
----
----
88.89%425K
303.00%403K
3,318.18%376K
----
----
--225K
Total other finance cost
----
----
-142.20%-1.58M
----
----
----
----
-4,460.00%-654K
----
----
Other net income (expense)
196.50%1.24M
114.09%236K
44.59%-5.21M
69.07%-1.38M
66.51%-865K
11.45%-1.28M
-87.15%-1.68M
-104.44%-9.4M
-84.78%-4.47M
-59.94%-2.58M
Gain on sale of security
--1.82M
----
----
----
----
----
----
----
----
----
Earnings from equity interest
55.06%-577K
113.63%236K
47.19%-5.28M
69.73%-1.4M
68.32%-865K
19.55%-1.28M
-66.28%-1.73M
-107.10%-10.01M
-81.24%-4.64M
-59.74%-2.73M
Special income (charges)
----
----
--0
----
----
----
----
--22K
----
----
-Gain on sale of property,plant,equipment
----
----
--0
----
----
----
----
--22K
----
----
Other non- operating income (expenses)
----
----
-86.71%78K
-85.14%22K
----
----
-61.64%56K
149.79%587K
4.96%148K
56.38%147K
Income before tax
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
-38.96%-14.83M
Income tax
Net income
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
-38.96%-14.83M
Net income continuous Operations
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
-38.96%-14.83M
Minority interest income
Net income attributable to the parent company
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
-38.96%-14.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
-38.96%-14.83M
Basic earnings per share
50.00%-0.07
29.41%-0.12
37.08%-0.56
38.10%-0.13
62.50%-0.12
22.22%-0.14
5.56%-0.17
13.59%-0.89
-5.00%-0.21
-33.33%-0.32
Diluted earnings per share
50.00%-0.07
29.41%-0.12
37.08%-0.56
38.10%-0.13
62.50%-0.12
22.22%-0.14
5.56%-0.17
13.59%-0.89
-5.00%-0.21
-33.33%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.57%5.94M-4.88%6.25M-28.12%23.41M-0.26%5.65M-55.42%5.56M-19.83%5.62M-11.32%6.57M-15.70%32.57M-16.80%5.67M37.87%12.47M
Selling and administrative expenses 10.10%1.82M10.00%2.18M-15.02%6.88M4.16%1.65M-24.34%1.6M-20.86%1.65M-14.40%1.98M-14.90%8.1M-21.56%1.59M2.53%2.11M
-General and administrative expense 10.10%1.82M10.00%2.18M-15.02%6.88M4.16%1.65M-24.34%1.6M-20.86%1.65M-14.40%1.98M-14.90%8.1M-21.56%1.59M2.53%2.11M
Research and development costs 3.68%4.11M-11.30%4.08M-32.46%16.53M-1.99%4M-61.75%3.97M-19.40%3.97M-9.92%4.59M-15.96%24.47M-14.79%4.08M48.26%10.37M
Operating profit -5.57%-5.94M4.88%-6.25M28.12%-23.41M0.26%-5.65M55.42%-5.56M19.83%-5.62M11.32%-6.57M15.70%-32.57M16.80%-5.67M-37.87%-12.47M
Net non-operating interest income expense 7.69%434K-15.96%316K142.20%1.58M19.50%380K88.89%425K303.00%403K3,318.18%376K4,460.00%654K4,075.00%318K2,145.45%225K
Non-operating interest income 7.69%434K-15.96%316K--------88.89%425K303.00%403K3,318.18%376K----------225K
Total other finance cost ---------142.20%-1.58M-----------------4,460.00%-654K--------
Other net income (expense) 196.50%1.24M114.09%236K44.59%-5.21M69.07%-1.38M66.51%-865K11.45%-1.28M-87.15%-1.68M-104.44%-9.4M-84.78%-4.47M-59.94%-2.58M
Gain on sale of security --1.82M------------------------------------
Earnings from equity interest 55.06%-577K113.63%236K47.19%-5.28M69.73%-1.4M68.32%-865K19.55%-1.28M-66.28%-1.73M-107.10%-10.01M-81.24%-4.64M-59.74%-2.73M
Special income (charges) ----------0------------------22K--------
-Gain on sale of property,plant,equipment ----------0------------------22K--------
Other non- operating income (expenses) ---------86.71%78K-85.14%22K---------61.64%56K149.79%587K4.96%148K56.38%147K
Income before tax 34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M-38.96%-14.83M
Income tax
Net income 34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M-38.96%-14.83M
Net income continuous Operations 34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M-38.96%-14.83M
Minority interest income
Net income attributable to the parent company 34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M-38.96%-14.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M-38.96%-14.83M
Basic earnings per share 50.00%-0.0729.41%-0.1237.08%-0.5638.10%-0.1362.50%-0.1222.22%-0.145.56%-0.1713.59%-0.89-5.00%-0.21-33.33%-0.32
Diluted earnings per share 50.00%-0.0729.41%-0.1237.08%-0.5638.10%-0.1362.50%-0.1222.22%-0.145.56%-0.1713.59%-0.89-5.00%-0.21-33.33%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg